Aldevron is a biotechnology company that specializes in the production of plasmid DNA, proteins, and mRNA for research, clinical, and commercial applications. Founded in 1998, the company has established itself as a leader in the field of genetic engineering and biotechnology services. Aldevron operates with a commitment to quality and innovation, providing essential components for the development of vaccines, gene therapies, and other advanced biotechnological solutions.

The company is headquartered in Fargo, North Dakota, and has expanded its operations to include facilities in Madison, Wisconsin, and Freiburg, Germany. Aldevron's state-of-the-art facilities are designed to meet the rigorous standards required for Good Manufacturing Practice (GMP) production, ensuring the highest quality products for its clients.

In terms of sustainability, Aldevron is actively working towards reducing its environmental impact. The company has implemented various initiatives to minimize waste and energy consumption across its facilities. However, detailed information on specific sustainability certifications or carbon footprint calculations is limited. Aldevron continues to explore opportunities to enhance its sustainability practices as part of its commitment to responsible corporate citizenship.